Drug Research
Monoclonal Antibodies Help COVID – 19 Hospitalisation To Dip
A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within two days to people who are tested positive for COVID-19.
The research compared the patients who...
Drug Research
New Antibiotic Discovery Helped By Australia Sepsis Study
Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new targets when it comes to developing antibiotics.
Professor Mark Schembri and Professor Mark Walker from the...
Drug Research
GSK, Scynexis Partner to Develop Brexafemme for Drug-Resistant Fungal Infections
Scynexis entered into an exclusive agreement with GSK for Brexafemme (ibrexafungerp), a U.S. FDA approved antifungal for the treatment of vaginal yeast infections and vulvovaginal candidiasis (VVC).
Under the terms of the global license agreement, GSK will pay Scynexis $90 million upfront, plus...
Drug Research
WACKER, CordenPharma, LMU and HU Berlin Train Machine Learning Algorithm for the Formulation of RNA Actives
Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched a project to accelerate the development of RNA-based drugs. The aim is to develop a...
Drug Research
Cancer Drugs Info Full of Gaps – Regulatory Action Needed
Drug manufacturers are not able to provide Europeans with the required information to gauge the benefits and defects of oncology medicines. This is as per the findings published in The BMJ, which demonstrate that the patient information leaflets consistently...
Drug Research
Australian Cell Graft For Nervous System Gets Funding Boost
Griffith University, based in Australia, has gone on to conduct a world-first study when it comes to cell transplantation so as to repair nervous system injuries and has thus received a tremendous boost of a $5.4 million fund extension...
Drug Research
UK Life Sciences Manufacturing To Get Aided With £277m Funds
A £277 million joint government-industry finance package will assist four UK life sciences companies in moving forward with life sciences manufacturing initiatives.
The Life Sciences Innovative Manufacturing Fund (LSIMF) has just released its first round of funding. Government financing of £17 million...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read